Elevance Health (ELV)

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-05-19 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Elevance Health, Inc. (ELV) CIK: 0001156039 --- Reporting Owner --- Name: Penczek Ronald W CIK: 0001659075 Role: Officer (CAO & Controller) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-05-19 | Code: M (Exercise of derivative) Shares: +654 | Price: $271.27 Total Value: $177,410.58 Shares Owned After: 4,763 | Ownership: D (Direct) Footnotes: [F1] Balance includes 10.21 shares acquired on March 25, 2026 through a dividend reinvestment plan. [Transaction #2] Security: Common Stock Date: 2026-05-19 | Code: M (Exercise of derivative) Shares: +877 | Price: $311.48 Total Value: $273,167.96 Shares Owned After: 5,640 | Ownership: D (Direct) [Transaction #3] Security: Common Stock Date: 2026-05-19 | Code: S (Open market sale) Shares: -1,531 | Price: $403.13 Total Value: $617,192.03 Shares Owned After: 4,109 | Ownership: D (Direct) Footnotes: [F2] This transaction was executed in multiple trades, each at the same price of $403.13. --- Derivative Transactions --- [Transaction #1] Security: Employee Stock Option (Right to Buy) Date: 2026-05-19 | Code: M (Exercise of derivative) Shares: -654 | Price: $0.00 Exercisable: N/A | Expires: 2030-03-02 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F3] Fully vested. [Transaction #2] Security: Employee Stock Option (Right to Buy) Date: 2026-05-19 | Code: M (Exercise of derivative) Shares: -877 | Price: $0.00 Exercisable: N/A | Expires: 2031-03-01 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F3] Fully vested. --- Footnotes (Complete Index) --- F1: Balance includes 10.21 shares acquired on March 25, 2026 through a dividend reinvestment plan. F2: This transaction was executed in multiple trades, each at the same price of $403.13. F3: Fully vested. --- Signature --- /s/ /s/ Kathleen S. Kiefer, Attorney in fact (2026-05-20)